SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)
26.65
0.00 (0.00%)
At close: Aug 11, 2025, 5:30 PM CET
Accolade Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 256.46M EUR in the quarter ending June 30, 2025, with 1.13% growth. This brings the company's revenue in the last twelve months to 975.68M, up 2.86% year-over-year. In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M with 6.51% growth.
Revenue (ttm)
975.68M
Revenue Growth
+2.86%
P/S Ratio
3.54
Revenue / Employee
203.69K
Employees
4,690
Market Cap
3.45B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
Sep 30, 2020 | 584.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UniCredit | 24.82B |
Intesa Sanpaolo | 25.58B |
Enel SpA | 77.79B |
Ferrari | 6.96B |
Assicurazioni Generali | 56.77B |
Eni S.p.A. | 87.03B |
Leonardo S.p.a. | 18.70B |
Poste Italiane | 13.75B |